Intellect Neurosciences Inc.

We are a research-based biotechnology company focused on the discovery, development and licensing of novel disease-modifying therapeutics for the treatment and prevention of rare neurodegenerative, “orphan”, diseases with high unmet medical need. Our internal drug discovery programs are focused on therapeutic applications of monoclonal antibodies.